Zdrowie i gospodarka · 26/09/2002

FDA Amends Endocrinologic and Metabolic Drugs Advisory Committee Meeting Notice

The FDA is updating the meeting notice for the Endocrinologic and Metabolic Drugs Advisory Committee, originally scheduled for September 25-27, 2002, due to administrative complications, with discussions on September 26 and 27 postponed to a later date.